Myogenic cellular transplantation and regeneration: Sorting through progenitor heterogeneity

Panminerva Medica

Volumn 46, Issue 1, 2004, Pages 81-91

  Jankowski, R J ^a,b   Huard, J ^a,b,c  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

CD34; Muscle, skeletal; Muscular dystrophies; Stem cells; Transplantation

Indexed keywords

CD34 ANTIGEN; CELL SURFACE PROTEIN; DESMIN; DYSTROPHIN; PROTEIN SCA 1; UNCLASSIFIED DRUG;

CELL ISOLATION; CELL POPULATION; CELL SELECTION; CELL SUSPENSION; GENETIC DISORDER; HUMAN; MUSCLE DEVELOPMENT; MUSCLE DISEASE; MUSCLE FIBER CULTURE; MUSCLE GROWTH; MUSCLE INJURY; MUSCLE REGENERATION; MUSCULAR DYSTROPHY; NONHUMAN; PROTEIN EXPRESSION; RELIABILITY; REVIEW; SKELETAL MUSCLE; STEM CELL TRANSPLANTATION;

ANIMALS; ANTIGENS, CD34; ANTIGENS, LY; DESMIN; DYSTROPHIN; HUMANS; MEMBRANE PROTEINS; MICE; MUSCLE FIBERS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; REGENERATION; STEM CELL TRANSPLANTATION;

EID: 4143057008     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Mauro A. Satellite cells of skeletal muscle fibers. J Biochem Biophys Cytol 1961;9:493-8.
2. Lipton BH, Schultz E. Developmental fate of skeletal muscle satellite cells. Science 1979;205:1292-4.
3. Bischoff R. The satellite cell and muscle regeneration. In: Engel AG, Franszini-Armstrong C, editors. Myology. New York: McGraw-Hill; 1994.p.97-118.
4. Goldring K, Partridge T, Watt D. Muscle stem cells. J Pathol 2002;197:457-67.
5. Ludolph DC, Konieczny SF. Transcription factor families: muscling in on the myogenic program. Faseb J 1995;9:1595-604.
6. Miller JB, Schaefer L, Dominov JA. Seeking muscle stem cells. Curr Top Dev Biol 1999;43:191-219.
7. Sabourin LA, Rudnicki MA. The molecular regulation of myogenesis. Clin Genet 2000;57:16-25.
8. Rantanen J, Hurme T, Lukka R, Heino J, Kalimo H. Satellite cell proliferation and the expression of myogenin and desmin in regenerating skeletal muscle: evidence for two different populations of satellite cells. Lab Invest 1995;72:341-7.
9. Schultz E. Satellite cell proliferative compartments in growing skeletal muscles. Dev Biol 1996;175:84-94.
10. Baroffio A, Bochaton-Piallat ML, Gabbiani G, Bader CR. Heterogeneity in the progeny of single human muscle satellite cells. Differentiation 1995;59:259-68.
11. Baroffio A, Hamann M, Bernheim L, Bochaton-Piallat ML, Gabbiani G, Bader CR. Identification of self-renewing myoblasts in the progeny of single human muscle satellite cells. Differentiation 1996;60:47-57.
12. Molnar G, Ho ML, Schroedl NA. Evidence for multiple satellite cell populations and a non-myogenic cell type that is regulated differently in regenerating and growing skeletal muscle. Tissue Cell 1996;28:547-56.
13. Yoshida N, Yoshida S, Koishi K, Masuda K, Nabeshima Y. Cell heterogeneity upon myogenic differentiation: down-regulation of MyoD and Myf-5 generates "reserve cells". J Cell Sci 1998;111(Pt 6):769-79.
14. Schultz E, Lipton BH. Skeletal muscle satellite cells: changes in proliferation potential as a function of age. Mech Ageing Dev 1982;20:377-83.
15. Schultz E, Jaryszak DL. Effects of skeletal muscle regeneration on the proliferation potential of satellite cells. Mech Ageing Dev 1985;30:63-72.
16. Asakura A, Komaki M, Rudnicki M. Muscle satellite cells are multipotential stem cells that exhibit myogenic, osteogenic, and adipogenic differentiation. Differentiation 2001;68:245-53.
17. Deasy BM, Huard J. Gene therapy and tissue engineering based on muscle-derived stem cells. Curr Opin Mol Ther 2002;4:382-9.
18. Seale P, Sabourin LA, Girgis-Gabardo A, Mansouri A, Gruss P, Rudnicki MA. Pax7 is required for the specification of myogenic satellite cells. Cell 2000;102:777-86.
19. De Angelis L, Berghella L, Coletta M, Lattanzi L, Zanchi M, Cusella-De Angelis MG et al. Skeletal myogenic progenitors originating from embryonic dorsal aorta coexpress endothelial and myogenic markers and contribute to postnatal muscle growth and regeneration. J Cell Biol 1999;147:869-78.
20. Seale P, Rudnicki MA. A new look at the origin, function, and "stem-cell" status of muscle satellite cells. Dev Biol 2000;218:115-24.
21. Cossu G, Mavilio F. Myogenic stem cells for the therapy of primary myopathies: wishful thinking or therapeutic perspective? J Clin Invest 2000;105:1669-74.
22. Gussoni E, Soneoka Y, Strickland CD, Buzney EA, Khan MK, Flint AF et al. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 1999;401:390-4.
23. Jackson KA, Mi T, Goodell MA. Hematopoietic potential of stem cells isolated from murine skeletal muscle. Proc Natl Acad Sci USA 1999;96:14482-6.
24. Torrente Y, Tremblay JP, Pisati F, Belicchi M, Rossi B, Sironi M et al. Intraarterial injection of muscle-derived CD34(+)Sca-1(+) stem cells restores dystrophin in mdx mice. J Cell Biol 2001;152:335-48.
25. Lee JY, Qu-Petersen Z, Cao B, Kimura S, Jankowski R, Cummins J et al. Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing. J Cell Biol 2000;150:1085-100.
26. Dell'Agnola C, Rabascio C, Mancuso P, Capillo M, Pruneri G, Gobbi A et al. In vitro and in vivo hematopoietic potential of human stem cells residing in muscle tissue. Exp Hematol 2002;30:905-14.
27. McKinney-Freeman SL, Jackson KA, Camargo FD, Ferrari G, Mavilio F, Goodell MA. Muscle-derived hematopoietic stem cells are hematopoietic in origin. Proc Natl Acad Sci USA 2002;99:1341-6.
28. Cao B, Zheng B, Jankowski RJ, Kimura S, Ikezawa M, Deasy B et al. Muscle stem cells differentiate into hematopoietic lineages but retain myogenic potential. Nat Cell Biol 2003;5:640-6.
29. Hagege AA, Menasche P. Cellular cardiomyoplasty: a new hope in heart failure? Heart 2000;84:465-6.
30. Muller-Ehmsen J, Kedes LH, Schwinger RH, Kloner RA. Cellular cardiomyoplasty: a novel approach to treat heart disease. Congest Heart Fail 2002;8:220-7.
31. Chancellor MB, Yokoyama T, Tirney S, Mattes CE, Ozawa H, Yoshimura N et al. Preliminary results of myoblast injection into the urethra and bladder wall: a possible method for the treatment of stress urinary incontinence and impaired detrusor contractility. Neurourol Urodyn 2000;19:279-87.
32. Yokoyama T, Pruchnic R, Lee JY, Chuang YC, Jumon H, Yoshimura N et al. Autologous primary muscle-derived cells transfer into the lower urinary tract. Tissue Eng 2001;7:395-404.
33. Yiou R, Dreyfus P, Chopin DK, Abbou CC, Lefaucheur JP. Muscle precursor cell autografting in a murine model of urethral sphincter injury. BJU Int 2002;89:298-302.
34. Hagege AA, Carrion C, Menasche P, Vilquin JT, Duboc D, Marolleau JP et al. Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy. Lancet 2003;361:491-2.
35. Pagani FD, DerSimonian H, Zawadzka A, Wetzel K, Edge AS, Jacoby DB et al. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. J Am Coll Cardiol 2003;41:879-88.
36. Menasche P, Hagege AA, Vilquin JT, Desnos M, Abergel E, Pouzet B et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 2003;41:1078-83.
37. Hoffman EP, Brown RH, Kunkel LM. Dystrophin: the protein product of the Duchene muscular dystrophy locus. Biotechnology 1992;24:457-66.
38. Bonilla E, Samitt CE, Miranda AF, Hays AP, Salviati G, DiMauro S et al. Duchenne muscular dystrophy: deficiency of dystrophin at the muscle cell surface. Cell 1988;54:447-52.
39. Bakker E, van Ommen G. Duchenne and Becker dystrophy. In: Emery AE, editor. Neuromuscular disorders: clinical and molecular genetics. New York: Wiley and Sons; 1998.p.59-85.
40. Campbell KP, Kahl SD. Association of dystrophin and an integral membrane glycoprotein. Nature 1989;338:259-62.
41. Partridge TA, Morgan JE, Coulton GR, Hoffman EP, Kunkel LM. Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature 1989;337:176-9.
42. Huard J, Bouchard JP, Roy R, Malouin F, Dansereau G, Labrecque C et al. Human myoblast transplantation: preliminary results of 4 cases. Muscle Nerve 1992;15:550-60.
43. Miller RG, Sharma KR, Pavlath GK, Gussoni E, Mynhier M, Lanctot AM et al. Myoblast implantation in Duchenne muscular dystrophy: the San Francisco study. Muscle Nerve 1997;20:469-78.
44. Tremblay JP, Bouchard JP, Malouin F, Theau D, Cottrell F, Collin H et al. Myoblast transplantation between monozygotic twin girl carriers of Duchenne muscular dystrophy. Neuromuscul Disord 1993;3:583-92.
45. Mendell JR, Kissel JT, Amato AA, King W, Signore L, Prior TW et al. Myoblast transfer in the treatment of Duchenne's muscular dystrophy. N Engl J Med 1995;333:832-8.
46. Qu Z, Balkir L, van Deutekom JC, Robbins PD, Pruchnic R, Huard J. Development of approaches to improve cell survival in myoblast transfer therapy. J Cell Biol 1998;142:1257-67.
47. Beauchamp JR, Morgan JE, Pagel CN, Partridge TA. Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source. J Cell Biol 1999;144:1113-22.
48. Gussoni E, Blau HM, Kunkel LM. The fate of individual myoblasts after transplantation into muscles of DMD patients. Nat Med 1997;3:970-7.
49. Qu-Petersen Z, Deasy B, Jankowski R, Ikezawa M, Cummins J, Pruchnic R et al. Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration. J Cell Biol 2002;157:851-64.
50. Webster C, Pavlath GK, Parks DR, Walsh FS, Blau HM. Isolation of human myoblasts with the fluorescence-activated cell sorter. Exp Cell Res 1988;174:252-65.
51. Lequerica JL, Mirabet V, Montero JA, Hurtado C, Piquer S, Carbonell F. In vitro proliferation, differentiation and immuno-magnetic bead purification of human myoblasts. Ann Transplant 1999;4:103-8.
52. Okada S, Nakauchi H, Nagayoshi K, Nishikawa S, Miura Y, Suda T. In vivo and in vitro stem cell function of c-kit- and Sca-1-positive murine hematopoietic cells. Blood 1992;80:3044-50.
53. Osawa M, Hanada K, Hamada H, Nakauchi H. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 1996;273:242-5.
54. Jankowski RJ, Haluszczak C, Trucco M, Huard J. Flow cytometric characterization of myogenic cell populations obtained via the preplate technique: potential for rapid isolation of muscle-derived stem cells. Hum Gene Ther 2001;12:619-28.
55. Krause DS, Fackler MJ, Civin CI, May WS. CD34: structure, biology, and clinical utility. Blood 1996;87:1-13.
56. Beauchamp JR, Heslop L, Yu DS, Tajbakhsh S, Kelly RG, Wernig A et al. Expression of CD34 and Myf5 defines the majority of quiescent adult skeletal muscle satellite cells. J Cell Biol 2000;151:1221-34.
57. Jankowski RJ, Deasy BM, Cao B, Gates C, Huard J. The role of CD34 expression and cellular fusion in the regeneration capacity of myogenic progenitor cells. J Cell Sci 2002;115:4361-74.
58. Mahmud N, Weiss P, Li F, Hoffman R. Primate skeletal muscle contains cells capable of sustaining in vitro hematopoiesis. Exp Hematol 2002;30:925-36.
59. Smythe GM, Hodgetts SI, Grounds MD. Problems and solutions in myoblast transfer therapy. J Cell Mol Med 2001;5:33-47.
60. Kitzmann M, Fernandez A. Crosstalk between cell cycle regulators and the myogenic factor MyoD in skeletal myoblasts. Cell Mol Life Sci 2001;58:571-9.
61. Kinoshita I, Vilquin JT, Tremblay JP. Pretreatment of myoblast cultures with basic fibroblast growth factor increases the efficacy of their transplantation in mdx mice. Muscle Nerve 1995;18:834-41.